Researchers observed that the median NIH Stroke Scale score was higher in patients with COVID-19 (OR = 1.69; 95% CI, 1.08-2.65) compared with patients without COVID-19.

All referred patients included in the development dataset were assessed by either a senior member of the stroke team or a research neurologist certified to use the NIH STROKE SCALE (NIHSS). All ...

Unfortunately, this scale is only recorded about 40 percent of the time; we separately derived a risk score in patients whose NIH Stroke Scale score was recorded.

Stroke patients presenting 6 to 24 hours after they were last known well could enjoy reductions in 90-day disability after thrombectomy whether they had qualified by clinical mismatch (OR 3.57, 95 ...

The researchers randomly assigned 760 patients (median age, 64 years; 31% women) with minor nondisabling acute ischemic stroke — defined as NIH Stroke Scale score of 5 or less, plus 1 point or ...

This was a nonblinded, randomized trial that enrolled patients with acute ischemic stroke aged 18 years or older. Patients had an NIH Stroke Scale (NIHSS) score of 2 or more for leg motor function ...

Secondary outcomes were in-hospital symptomatic ICHs (ECASS-2 criteria, i.e., NIH Stroke Scale score increase of ≥ 4 points) and any in-hospital ICHs. “A total of 3,953 patients were treated ...

BRILINTA is indicated to reduce the risk of stroke in patients with acute ischemic stroke (NIH Stroke Scale ≤5) or high-risk transient ischemic attack (TIA). DOSING .

Patients were randomized to receive ticagrelor 90mg twice daily or matching placebo, in addition to aspirin daily, within 24 hours of onset of acute ischemic stroke or high-risk TIA symptoms and ...